Tomoaki Ida

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)